about
Mammalian Pathogenesis and Transmission of H7N9 Influenza Viruses from Three Waves, 2013-2015Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and MiceA novel A(H7N2) influenza virus isolated from a veterinarian caring for cats in a New York City animal shelter causes mild disease and transmits poorly in the ferret model.Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.Characterization of full-length MHC class II sequences in Indonesian and Vietnamese cynomolgus macaquesUltra-high resolution HLA genotyping and allele discovery by highly multiplexed cDNA amplicon pyrosequencingFull-length novel MHC class I allele discovery by next-generation sequencing: two platforms are better than oneNeuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013.Infection and replication of influenza virus at the ocular surface.Antigenically Diverse Swine Origin H1N1 Variant Influenza Viruses Exhibit Differential Ferret Pathogenesis and Transmission Phenotypes.Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.Infection of Cultured Mammalian Cells with Aerosolized Influenza Virus
P50
Q28392524-117844E9-2A0B-4481-8F62-4E5F84ABD9E7Q30372696-2FC67606-B068-4510-BEFC-EAD90DBF53A9Q30377312-20CC4A02-62BB-4063-B675-88D047743A81Q30402085-3D8CD436-5F45-4005-899F-F12A7BB53E8BQ30402500-01B0E6B4-7F3F-43D1-8CE3-68EBCDF638ACQ33912582-07610961-0A21-4419-8499-6DB69E09F5DAQ34367478-53C44C09-559D-455A-B1B1-09E18BA2D28AQ35045019-A4E12EEF-C4B2-4D4D-9705-491893D83397Q36408162-7B79F359-A4B8-4E59-BBB2-269FD261F5C4Q40411664-7E161751-4B6F-4C78-AD2B-0D1062A606BEQ41123104-C835641B-9E82-4778-8664-40BFB02556B2Q41932784-67243479-9747-450C-ACEF-E986FB41A964Q41932792-08E73C09-1629-43C3-BB5E-08EFB58AA95EQ47555922-02E73CCD-3392-4D7D-840B-133EBEE9D2A0Q54255837-AE7156D8-F86B-4D66-BE70-BB5E8D22C350Q56535707-C549440F-F8FE-4D0B-99FB-C3C1BB6209B6Q57285033-58846CB7-8B1A-40EF-98AB-6EF5D457C92BQ59353774-32790340-789B-401B-98DD-D66EB817916A
P50
name
Hannah M Creager
@en
type
label
Hannah M Creager
@en
prefLabel
Hannah M Creager
@en